Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase
- 1 August 2006
- journal article
- Published by Springer Nature in Nature
- Vol. 442 (7102) , 576-579
- https://doi.org/10.1038/nature04856
Abstract
Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.Keywords
This publication has 28 references indexed in Scilit:
- Genotype-Phenotype Correlations for Nervous System Tumors in Neurofibromatosis 2: A Population-Based StudyAmerican Journal of Human Genetics, 2004
- Merlin and ERM proteins: unappreciated roles in cancer development?Nature Reviews Cancer, 2003
- Dimerization of cGMP-dependent protein kinase 1α and the myosin-binding subunit of myosin phosphatase: role of leucine zipper domainsCellular Signalling, 2003
- NF2: The wizardry of merlinGenes, Chromosomes and Cancer, 2003
- KEPI, a PKC-dependent Protein Phosphatase 1 Inhibitor Regulated by MorphineJournal of Biological Chemistry, 2002
- Structural Basis for Neurofibromatosis Type 2Journal of Biological Chemistry, 2002
- A Novel Phosphoprotein Inhibitor of Protein Type-1 Phosphatase HoloenzymesBiochemistry, 1999
- Regulation of Myosin Phosphatase by a Specific Interaction with cGMP- Dependent Protein Kinase IαScience, 1999
- The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation.Genes & Development, 1997
- New insights into the neurofibromatosesCurrent Opinion in Neurology, 1994